PGBD1
geneOn this page
Also known as HUCEP-4dJ874C20.4SCAND4
Summary
PGBD1 (piggyBac transposable element derived 1, HGNC:19398) is a protein-coding gene on chromosome 6p22.1, encoding PiggyBac transposable element-derived protein 1 (Q96JS3). Transposase-derived from PiggyBac DNA transposons.
The piggyBac family of proteins, found in diverse animals, are transposases related to the transposase of the canonical piggyBac transposon from the moth, Trichoplusia ni. This family also includes genes in several genomes, including human, that appear to have been derived from the piggyBac transposons. This gene belongs to the subfamily of piggyBac transposable element derived (PGBD) genes. The PGBD proteins appear to be novel, with no obvious relationship to other transposases, or other known protein families. This gene product is specifically expressed in the brain, however, its exact function is not known. Alternative splicing results in multiple transcript variants encoding the same protein.
Source: NCBI Gene 84547 — RefSeq curated summary.
At a glance
- GWAS associations: 27
- Clinical variants (ClinVar): 118 total
- MANE Select transcript:
NM_032507
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19398 |
| Approved symbol | PGBD1 |
| Name | piggyBac transposable element derived 1 |
| Location | 6p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HUCEP-4, dJ874C20.4, SCAND4 |
| Ensembl gene | ENSG00000137338 |
| Ensembl biotype | protein_coding |
| OMIM | 621244 |
| Entrez | 84547 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000259883, ENST00000682144, ENST00000918204, ENST00000918205, ENST00000918206, ENST00000918207
RefSeq mRNA: 3 — MANE Select: NM_032507
NM_001184743, NM_001386059, NM_032507
CCDS: CCDS4648
Canonical transcript exons
ENST00000682144 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000928926 | 28285551 | 28285707 |
| ENSE00000928927 | 28287080 | 28287168 |
| ENSE00000928928 | 28296816 | 28296945 |
| ENSE00000928929 | 28297895 | 28297991 |
| ENSE00001212131 | 28281572 | 28281918 |
| ENSE00001548550 | 28300724 | 28302549 |
| ENSE00003917026 | 28283776 | 28284209 |
Expression profiles
Bgee: expression breadth ubiquitous, 177 present calls, max score 87.71.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.8017 / max 75.3514, expressed in 1567 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 66627 | 6.9983 | 1550 |
| 66626 | 0.8034 | 505 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.71 | gold quality |
| cortical plate | UBERON:0005343 | 81.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 81.46 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.41 | gold quality |
| ventricular zone | UBERON:0003053 | 79.54 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 78.85 | gold quality |
| cerebellar cortex | UBERON:0002129 | 78.65 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 78.33 | gold quality |
| cerebellum | UBERON:0002037 | 77.22 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.09 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 76.93 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 76.92 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 76.53 | gold quality |
| right frontal lobe | UBERON:0002810 | 76.08 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 75.03 | gold quality |
| lower esophagus | UBERON:0013473 | 74.98 | gold quality |
| apex of heart | UBERON:0002098 | 74.87 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 74.78 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 74.54 | gold quality |
| mucosa of stomach | UBERON:0001199 | 74.34 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 74.24 | gold quality |
| primary visual cortex | UBERON:0002436 | 74.24 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.18 | gold quality |
| thoracic aorta | UBERON:0001515 | 74.16 | gold quality |
| ascending aorta | UBERON:0001496 | 74.07 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 73.80 | gold quality |
| body of uterus | UBERON:0009853 | 73.67 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 73.63 | gold quality |
| neocortex | UBERON:0001950 | 73.58 | gold quality |
| left coronary artery | UBERON:0001626 | 73.39 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.07 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
31 targeting PGBD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-3912-5P | 99.95 | 66.11 | 925 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-944 | 99.82 | 70.85 | 3042 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-323A-3P | 99.79 | 70.30 | 1739 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-7159-3P | 99.51 | 70.17 | 1920 |
| HSA-MIR-29A-5P | 99.08 | 68.59 | 1813 |
| HSA-MIR-548L | 99.06 | 70.90 | 2560 |
| HSA-MIR-10B-3P | 99.04 | 66.98 | 988 |
| HSA-MIR-654-3P | 98.38 | 67.61 | 905 |
| HSA-MIR-3074-3P | 97.83 | 67.26 | 922 |
| HSA-MIR-4288 | 97.11 | 67.23 | 1636 |
| HSA-MIR-6730-3P | 97.03 | 67.54 | 889 |
Literature-anchored findings (GeneRIF, showing 5)
- Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. (PMID:22037552)
- The genes HIST1H2BJ, PRSS16, and PGBD1 were not associated with Japanese patients with schizophrenia. (PMID:22488895)
- the high level of transfection achieved with PB may have significant advantages in basic scientific research for dental tissue engineering applications, such as functional studies of genes and proteins (PMID:26208039)
- Expression levels in the transposon-based cells were two to five -folds more than those created by conventional method except for the IRES-mediated ones, in which the observed difference increased more than 100-fold (PMID:28662065)
- A Novel Gene Controls a New Structure: PiggyBac Transposable Element-Derived 1, Unique to Mammals, Controls Mammal-Specific Neuronal Paraspeckles. (PMID:36205081)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Pgbd1 | ENSMUSG00000055313 |
Paralogs (30): ZNF263 (ENSG00000006194), ZNF213 (ENSG00000085644), ZNF500 (ENSG00000103199), ZKSCAN1 (ENSG00000106261), ZNF205 (ENSG00000122386), ZSCAN9 (ENSG00000137185), ZNF215 (ENSG00000149054), ZSCAN12 (ENSG00000158691), ZNF394 (ENSG00000160908), ZNF75A (ENSG00000162086), ZSCAN21 (ENSG00000166529), ZNF232 (ENSG00000167840), ZNF24 (ENSG00000172466), ZNF449 (ENSG00000173275), ZSCAN4 (ENSG00000180532), ZSCAN22 (ENSG00000182318), ZNF75D (ENSG00000186376), ZNF396 (ENSG00000186496), ZNF397 (ENSG00000186812), ZSCAN30 (ENSG00000186814), ZKSCAN4 (ENSG00000187626), ZSCAN23 (ENSG00000187987), ZKSCAN3 (ENSG00000189298), ZSCAN16 (ENSG00000196812), ZSCAN25 (ENSG00000197037), ZSCAN26 (ENSG00000197062), ZNF165 (ENSG00000197279), ZKSCAN8 (ENSG00000198315), ZSCAN31 (ENSG00000235109), ZNF853 (ENSG00000236609)
Protein
Protein identifiers
PiggyBac transposable element-derived protein 1 — Q96JS3 (reviewed: Q96JS3)
Alternative names: Cerebral protein 4
All UniProt accessions (1): Q96JS3
UniProt curated annotations — full annotation on UniProt →
Function. Transposase-derived from PiggyBac DNA transposons. Although it has been fully domesticated and lacks transposase activity, PGBD1 has acquired DNA-binding capability. It preferentially binds in and around genes involved in neuronal development, leading to their transcriptional pausing. Notably, PGBD1 suppresses paraspeckle assembly in neuronal cells.
Subcellular location. Nucleus.
Miscellaneous. PGBD1 is a nonmonotreme mammal-specific horizontally transferred gene.
RefSeq proteins (3): NP_001171672, NP_001372988, NP_115896* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001190 | SRCR | Domain |
| IPR003309 | SCAN_dom | Domain |
| IPR029526 | PGBD | Domain |
| IPR038269 | SCAN_sf | Homologous_superfamily |
| IPR052638 | PiggyBac_TE-derived | Family |
Pfam: PF02023, PF13843
UniProt features (16 total): sequence variant 8, sequence conflict 2, region of interest 2, chain 1, domain 1, modified residue 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96JS3-F1 | 66.92 | 0.37 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 360, 218
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 45 (showing top):
GOBP_NEUROGENESIS, JAATINEN_HEMATOPOIETIC_STEM_CELL_UP, VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP, ZHENG_BOUND_BY_FOXP3, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, JOHNSTONE_PARVB_TARGETS_2_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, FEV_TARGET_GENES, SNIP1_TARGET_GENES, MIR4795_3P, MIR548N, MIR944, MIR6780A_5P, MIR29A_5P, MIR3074_3P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), neurogenesis (GO:0022008)
GO Molecular Function (5): DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), identical protein binding (GO:0042802), sequence-specific DNA binding (GO:0043565), protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 1 |
| nervous system development | 1 |
| cell differentiation | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| protein binding | 1 |
| DNA binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
662 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PGBD1 | NKAPL | Q5M9Q1 | 596 |
| PGBD1 | TNK1 | Q13470 | 573 |
| PGBD1 | PGBD5 | Q8N414 | 534 |
| PGBD1 | THAP9 | Q9H5L6 | 530 |
| PGBD1 | PRSS16 | Q9NQE7 | 526 |
| PGBD1 | POGK | Q9P215 | 490 |
| PGBD1 | GALP | Q9UBC7 | 484 |
| PGBD1 | GIN1 | Q9NXP7 | 477 |
| PGBD1 | ZBED8 | Q8IZ13 | 466 |
| PGBD1 | SIPA1L3 | O60292 | 464 |
| PGBD1 | ZNF862 | O60290 | 450 |
| PGBD1 | GAB2 | Q9UQC2 | 447 |
| PGBD1 | DKKL1 | Q9UK85 | 434 |
| PGBD1 | APOE | P02649 | 418 |
| PGBD1 | NAIF1 | Q69YI7 | 415 |
IntAct
105 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PGBD1 | SCAND1 | psi-mi:“MI:0915”(physical association) | 0.940 |
| SCAND1 | PGBD1 | psi-mi:“MI:0915”(physical association) | 0.940 |
| PGBD1 | SCAND1 | psi-mi:“MI:0914”(association) | 0.940 |
| PGBD1 | ZNF24 | psi-mi:“MI:0915”(physical association) | 0.900 |
| ZNF24 | PGBD1 | psi-mi:“MI:0915”(physical association) | 0.900 |
| PGBD1 | ZNF24 | psi-mi:“MI:0914”(association) | 0.900 |
| PGBD1 | ZNF446 | psi-mi:“MI:0915”(physical association) | 0.800 |
| ZNF446 | PGBD1 | psi-mi:“MI:0915”(physical association) | 0.800 |
| PGBD1 | ZSCAN22 | psi-mi:“MI:0915”(physical association) | 0.790 |
| ZSCAN22 | PGBD1 | psi-mi:“MI:0915”(physical association) | 0.790 |
BioGRID (70): PGBD1 (Two-hybrid), PGBD1 (Two-hybrid), PGBD1 (Two-hybrid), PGBD1 (Two-hybrid), PGBD1 (Two-hybrid), PGBD1 (Two-hybrid), PGBD1 (Two-hybrid), ZSCAN22 (Two-hybrid), PGBD1 (Affinity Capture-MS), PGBD1 (Affinity Capture-MS), PGBD1 (Affinity Capture-MS), PGBD1 (Affinity Capture-MS), PGBD1 (Affinity Capture-MS), MEOX2 (Two-hybrid), NR4A1 (Two-hybrid)
ESM2 similar proteins: A3KMX0, A4IFA3, A4IGY9, A4Z943, A4Z944, B8QB46, D2EAC2, E1C2V1, O43422, O60290, P10911, P35125, P86452, Q13075, Q2NKX8, Q3UPF5, Q49AG3, Q5FWF4, Q5SVZ6, Q5T890, Q5TKR9, Q6DJS0, Q6EKJ0, Q6R2W3, Q6YI93, Q7Z2W4, Q80WE4, Q86UP8, Q86VD1, Q8BZ21, Q8N8K9, Q8QMP8, Q8TDB6, Q8WML3, Q92794, Q96JM7, Q96JS3, Q99388, Q99NI3, Q9CUX1
Diamond homologs: A1YEP8, A1YEQ3, A1YEV9, A1YFW2, A1YFW6, A1YG26, A1YG48, A1YG60, A1YGJ4, A1YGK6, A2T6E3, A2T6V8, A2T6W2, A2T712, A2T736, A2T7D2, A2T7D7, A2T7F2, A2T7F4, A2T7L7, A2T812, A6QNZ0, A6QPT6, B2KFW1, O14709, O14771, O14978, O15535, O43309, O60304, O95125, P10073, P17022, P17028, P17029, P17040, P28698, P49910, P51815, P59923
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
118 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 97 |
| Likely benign | 8 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1064 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:28284187:G:GT | donor_gain | 1.0000 |
| 6:28296942:A:G | donor_gain | 1.0000 |
| 6:28296944:GA:G | donor_gain | 1.0000 |
| 6:28296946:G:GG | donor_gain | 1.0000 |
| 6:28297893:A:AG | acceptor_gain | 1.0000 |
| 6:28297894:G:GG | acceptor_gain | 1.0000 |
| 6:28300722:A:AG | acceptor_gain | 1.0000 |
| 6:28300722:A:AT | acceptor_loss | 1.0000 |
| 6:28300723:G:GG | acceptor_gain | 1.0000 |
| 6:28300723:G:GT | acceptor_loss | 1.0000 |
| 6:28300723:GA:G | acceptor_gain | 1.0000 |
| 6:28300723:GAGA:G | acceptor_gain | 1.0000 |
| 6:28281711:C:G | donor_gain | 0.9900 |
| 6:28283774:A:AG | acceptor_gain | 0.9900 |
| 6:28283775:G:GG | acceptor_gain | 0.9900 |
| 6:28284187:G:T | donor_gain | 0.9900 |
| 6:28284206:ACAG:A | donor_loss | 0.9900 |
| 6:28284208:AG:A | donor_loss | 0.9900 |
| 6:28284209:GG:G | donor_loss | 0.9900 |
| 6:28284211:T:A | donor_loss | 0.9900 |
| 6:28284214:G:T | donor_gain | 0.9900 |
| 6:28285698:GAA:G | donor_gain | 0.9900 |
| 6:28285701:G:GG | donor_gain | 0.9900 |
| 6:28285703:GAGTG:G | donor_gain | 0.9900 |
| 6:28285705:GTG:G | donor_gain | 0.9900 |
| 6:28287168:GGT:G | donor_loss | 0.9900 |
| 6:28287169:G:GA | donor_loss | 0.9900 |
| 6:28287170:TAA:T | donor_loss | 0.9900 |
| 6:28296925:T:G | donor_gain | 0.9900 |
| 6:28296941:GA:G | donor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000113926 (6:28299409 G>T), RS1000448868 (6:28286209 T>C), RS1000472666 (6:28279749 T>G), RS1000600442 (6:28293919 A>C,G), RS1000741916 (6:28294330 G>T), RS1000819624 (6:28285312 T>C), RS1001124101 (6:28286495 A>G), RS1001769562 (6:28293458 T>A), RS1002149807 (6:28281535 C>G,T), RS1002176363 (6:28301586 G>A,T), RS1002278051 (6:28295677 C>A,T), RS1002388370 (6:28288399 A>G), RS1002673161 (6:28290003 T>C), RS1002714179 (6:28290377 T>C), RS1002828133 (6:28288772 G>A)
Disease associations
OMIM: gene MIM:621244 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
27 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003997_12 | Myopia | 1.000000e-12 |
| GCST004521_112 | Autism spectrum disorder or schizophrenia | 3.000000e-26 |
| GCST004521_115 | Autism spectrum disorder or schizophrenia | 3.000000e-16 |
| GCST004521_166 | Autism spectrum disorder or schizophrenia | 4.000000e-24 |
| GCST004521_212 | Autism spectrum disorder or schizophrenia | 5.000000e-14 |
| GCST004521_23 | Autism spectrum disorder or schizophrenia | 2.000000e-11 |
| GCST004521_43 | Autism spectrum disorder or schizophrenia | 2.000000e-27 |
| GCST004521_6 | Autism spectrum disorder or schizophrenia | 2.000000e-15 |
| GCST004521_7 | Autism spectrum disorder or schizophrenia | 2.000000e-15 |
| GCST004521_73 | Autism spectrum disorder or schizophrenia | 8.000000e-11 |
| GCST004521_77 | Autism spectrum disorder or schizophrenia | 1.000000e-19 |
| GCST004748_92 | Lung cancer | 2.000000e-12 |
| GCST004750_90 | Squamous cell lung carcinoma | 4.000000e-11 |
| GCST007269_245 | Pulse pressure | 6.000000e-15 |
| GCST008921_4 | Asthma and major depressive disorder | 2.000000e-11 |
| GCST008921_6 | Asthma and major depressive disorder | 1.000000e-09 |
| GCST010002_50 | Refractive error | 4.000000e-34 |
| GCST010083_222 | Hemoglobin levels | 1.000000e-44 |
| GCST010142_16 | Fish- and plant-related diet | 2.000000e-10 |
| GCST010142_19 | Fish- and plant-related diet | 4.000000e-10 |
| GCST010142_34 | Fish- and plant-related diet | 7.000000e-09 |
| GCST010142_35 | Fish- and plant-related diet | 8.000000e-09 |
| GCST010142_42 | Fish- and plant-related diet | 1.000000e-08 |
| GCST010142_7 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010702_75 | Subcortical volume (MOSTest) | 3.000000e-11 |
| GCST010703_272 | Brain morphology (MOSTest) | 7.000000e-16 |
| GCST010979_11 | Kawasaki disease | 7.000000e-10 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
| EFO:0004509 | hemoglobin measurement |
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression | 2 |
| FR900359 | decreases phosphorylation | 1 |
| urushiol | decreases expression | 1 |
| trichostatin A | affects expression | 1 |
| sodium arsenite | affects cotreatment, decreases expression, increases abundance | 1 |
| butyraldehyde | decreases expression | 1 |
| manganese chloride | affects cotreatment, decreases expression, increases abundance | 1 |
| Temozolomide | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects cotreatment, decreases expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Doxorubicin | affects expression | 1 |
| Estradiol | affects cotreatment, increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Manganese | affects cotreatment, decreases expression, increases abundance | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Quercetin | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Kawasaki disease